4//SEC Filing
Kessler Paul D. 4
Accession 0001455244-11-000025
CIK 0000072444other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 10:39 AM ET
Size
6.4 KB
Accession
0001455244-11-000025
Insider Transaction Report
Form 4
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Transactions
- Sale
Common Stock
2011-05-16$5.53/sh−7,500$41,447→ 115,171 total - Sale
Common Stock
2011-05-16$5.48/sh−4,876$26,712→ 110,295 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001428524
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 10:39 AM ET
- Size
- 6.4 KB